Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current developments in single photon radiopharmaceuticals for tumor imaging.

K Ozker1

  • 1Medical College of Wisconsin, 9200 W Wisconsin Avenue, Milwaukee, WI 53226, USA. ozker@mcw.edu

Current Pharmaceutical Design
|July 21, 2000
PubMed
Summary

Radiolabeled peptides and amino acids show promise for nuclear medicine tumor imaging due to rapid clearance and tumor localization. Technetium-99m somatostatin analogues and Iodine-123 alpha methyl tyrosine are effective, with ongoing research into glucose analogues.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Vienna protocol and perspectives in radionuclide therapy.

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...·2011
Same author

Breast carcinoma cell uptake and biodistribution of technetium-99m-carboxymethyl benzylamide dextran.

Anticancer research·2001
Same author

Correlation of technetium-99m MIBI and thallium-201 retention in solitary cold thyroid nodules with postoperative histopathology.

European journal of nuclear medicine·2000
Same author

Biodistribution of 99Tcm-labelled 5-thio-D-glucose.

Nuclear medicine communications·1999
Same author

Preclinical evaluation of benzoporphyrin derivative combined with a light-emitting diode array for photodynamic therapy of brain tumors.

Pediatric neurosurgery·1999
Same author

Stop-flow studies of solute uptake in rat lungs.

Journal of applied physiology (Bethesda, Md. : 1985)·1998

Area of Science:

  • Nuclear Medicine
  • Radiopharmaceutical Chemistry
  • Oncology

Background:

  • Peptides and amino acids labeled with single photon gamma emitters are increasingly used in nuclear medicine for tumor imaging.
  • Radiolabeled peptides offer advantages over antibodies, including reduced immunogenicity, smaller size, faster tumor localization, and quicker total body clearance.
  • Current research focuses on developing novel radiotracers for enhanced diagnostic capabilities.

Purpose of the Study:

  • To review the development and application of single photon-emitting radiolabeled peptides and amino acids for tumor imaging.
  • To highlight the advantages of radiolabeled peptides in nuclear medicine diagnostics.
  • To discuss recent advancements and challenges in developing specific radiotracers, including somatostatin analogues and glucose analogues.

Related Experiment Videos

Main Methods:

  • Review of existing literature on radiolabeled peptides and amino acids for tumor imaging.
  • Analysis of studies involving specific radiotracers like Tc-99m somatostatin analogues and I-123 alpha methyl tyrosine.
  • Exploration of the synthesis and interaction of novel radiolabeled glucose analogues with glucose transporters.

Main Results:

  • Indium-111 labeled lanreotide demonstrated high success in localizing neuroendocrine tumors.
  • Iodine-123 labeled alpha methyl tyrosine showed carrier-mediated transport into tumors.
  • Development of stable single photon glucose analogues that interact with glucose transporters has been achieved, although not yet suitable for hexokinase reaction.

Conclusions:

  • Radiolabeled peptides and amino acids are valuable tools in nuclear medicine for tumor imaging, offering improved pharmacokinetic profiles compared to antibodies.
  • Specific analogues like In-111 lanreotide and I-123 alpha methyl tyrosine show significant potential for diagnosing specific tumor types.
  • Further research into glucose analogues interacting with glucose transporters holds promise for developing new imaging agents.